e-learning
resources
Paris 2018
Wednesday, 19.09.2018
New determinants of cardiovascular morbidity in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low FFMI according to ESPEN cut-offs is a strong independent predictor of mortality in patients with COPD
I. Sarc (golnik, Slovenia), T. Kosten (golnik, Slovenia), T. Hafner (golnik, Slovenia), B. Zupanc (golnik, Slovenia), K. Ziherl (golnik, Slovenia)
Source:
International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Session:
New determinants of cardiovascular morbidity in COPD
Session type:
Oral Presentation
Number:
5165
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Sarc (golnik, Slovenia), T. Kosten (golnik, Slovenia), T. Hafner (golnik, Slovenia), B. Zupanc (golnik, Slovenia), K. Ziherl (golnik, Slovenia). Low FFMI according to ESPEN cut-offs is a strong independent predictor of mortality in patients with COPD. 5165
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Validation of bode index as a predictor of mortality in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Body mass index (BMI) is an independent risk factor for exacerbation in patients with COPD
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008
The index distance-saturation product like predicting of mortality in patients with COPD
Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment
Year: 2008
Association between adiposity measures and COPD risk in Chinese adults
Source: Eur Respir J, 55 (4) 1901899; 10.1183/13993003.01899-2019
Year: 2020
The value of the body composition analysis on COPD patients in different groups according to BMI
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Management of high risk patients with COPD, identified by the DOSE index, in general practice
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009
BMI and risk for death in COPD
Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases
Year: 2011
The impact of comorbidities related to BMI in COPD patients
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Impact of high body mass index in mortality in hospitalized patients with CAP: Results from the CAPO international cohort study
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Body composition by bioelectrical impedance predicts mortality in COPD patients
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Association between comorbidities, disease severity and body mass index in COPD patients
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020
BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
Karnofsky index as predictor of exacerbations in moderate and severe COPD patients
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
A longitudinal study of the relationship between serial changes in BODE index, mortality and readmissions in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Sarcopenia index correlates with COPD clinical outcomes.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
A predictive model for classifying COPD patients according to CT emphysema extent by using functional data and BMI
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Pro-adrenomedullin is a predictive marker for all-cause mortality in stable COPD: An analysis of the COSYCONET study
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020
SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept